STOCKHOLDERS’ DEFICIENCY AND MEZZANINE EQUITY (Tables)

9 Months Ended

Dec. 31, 2023

Equity [Abstract]

SCHEDULE OF SERIES B PREFERRED STOCK FOR MEZZANINE EQUITY

	2023
		$
Balance beginning of period – March 31		—
Net proceeds received pursuant to the issuance of preferred shares		1,900,000
Recognition of derivative liabilities (Note 8)		(642,417	)
Conversion into common shares		(228,727	)
Balance end of period – December 31		1,028,856

SCHEDULE OF WARRANTS OUTSTANDING

Warrant activity during the nine months ended December 31, 2023 is indicated below:

	Broker Warrants		Consultant and Noteholder Warrants			Warrants Issued on Convertible Notes		Total
As at March 31, 2023		139,865		279,341			888,277		1,307,483
Expired/cancelled		—		(25,347	)		—		(25,347	)
Exercised		—		—			—		—
Issued		69,062		—			868,029		937,091
As at December 31, 2023		208,927		253,994			1,756,306		2,219,227
Exercise Price	$	2.09 to $37.56	$	2.69 to $14.40		$	6.36 to $9.00
Expiration Date		August 2026 to October 2033		December 2028 to December 2032			January 2024 to October 2024

SCHEDULE OF STOCK OPTION ACTIVITIES

The following table summarizes the stock option activities during the nine months ended December 31, 2023:

	Number of Options			Weighted Average Exercise Price
Outstanding at March 31, 2023		1,264,890		$	9.29
Granted		3,585		$	2.79
Exercised		—		$	—
Expired/Forfeited		(28,214	)	$	7.80
Outstanding at December 31, 2023		1,240,261		$	9.32

SCHEDULE OF FAIR VALUE OF OPTION GRANTED USING VALUATION ASSUMPTIONS

The fair value of each option granted is estimated at the time of grant using multi-nominal lattice model using the following assumptions, for each of the respective nine month periods ended December 31:

	2023		2022
Exercise price ($)		2.79		4.80
Risk free interest rate (%)		3.85		4.06
Expected term (Years)		10.0		5.00
Expected volatility (%)		117.1		113.9
Expected dividend yield (%)		0.00		0.00
Fair value of option ($)		2.30		3.92
Expected forfeiture (attrition) rate (%)		0.00		0.00